top of page
NMX stays on the cutting edge of drug discovery research by constantly expanding and redefining what can be achieved by our biochemical and biophysical tools of choice.
This section features a selection of recently published developments.
Fragment-Based Phenotypic Lead Discovery To Identify New Drug Seeds That Target Infectious Diseases
Yann Ayotte, Eve Bernet, François Bilodeau, Mena Cimino, Dominic Gagnon, Marthe Lebughe,
Maxime Mistretta, Paul Ogadinma, Sarah-Lisa Ouali, Aïssatou Aïcha Sow, Laurent Chatel-Chaix,
Albert Descoteaux, Giulia Manina, Dave Richard, Frédéric Veyrier, and Steven R. LaPlante
ACS Chem. Biol. (2021)
bottom of page